Studies on the coumarin anticoagulant drugs: interaction of human plasma albumin and warfarin sodium

The Journal of Clinical Investigation
R A O'Reilly

Abstract

In studies by continuous flow electrophoresis the coumarin anticoagulant drug warfarin sodium was found to be bound solely to the albumin fraction of the plasma proteins. The interaction was studied in detail by equilibrium dialysis of solutions of crystalline human plasma albumin and warfarin sodium. Analysis of the data showed that albumin possesses a single strong binding site for warfarin with an association constant of 154,000 at 3 degrees C and secondary classes of several sites with a much lower affinity. The free energy of binding for the first anion determined at 3 degrees and 37 degrees C was -6.54 and -7.01 kcal per mole, respectively. The standard enthalpy change for the interaction was -3.48 kcal per mole, and the entropy change was +11.2 U. The negative enthalpy change was surprisingly large and the positive entropy change small for an anion-albumin interaction, suggesting significant nonionic binding. The inability to saturate the albumin binding sites, even when high concentrations of warfarin were used, is consistent with a reversible configurational alteration of the albumin molecule during the binding process. The thermodynamic data indicate that the albumin binding sites for warfarin sodium are formed during...Continue Reading

References

Dec 20, 1965·Journal of the American Chemical Society·C HanschG L Lawrence
Sep 1, 1965·Journal of Pharmaceutical Sciences·C F Hiskey, V Melnitchenko
Feb 1, 1966·The Journal of Clinical Investigation·K J Baker, S E Bradley
Nov 1, 1959·The Journal of Clinical Investigation·S A BERSON, R S YALOW
May 1, 1962·The Journal of Clinical Investigation·K STERLINGM TABACHNICK
Oct 1, 1963·The Journal of Clinical Investigation·R A O'REILLYL S LEONG
Oct 15, 1964·The New England Journal of Medicine·R A O'REILLYM L KROPATKIN
Sep 1, 1964·The Journal of Clinical Investigation·K STERLING

❮ Previous
Next ❯

Citations

Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·B Hüthwohl, E Jähnchen
Jan 1, 1981·European Journal of Drug Metabolism and Pharmacokinetics·J PaubelC P Pinazzi
Dec 1, 1973·Comparative and General Pharmacology·J D Baggot, L E Davis
Jul 7, 1987·Biochimica Et Biophysica Acta·H W Dirr, J C Schabort
May 15, 2003·Archives of Biochemistry and Biophysics·S M TwineJ M East
Oct 24, 2002·Biochemical Pharmacology·Nicole A KratochwilPaul R Gerber
Oct 18, 2001·International Journal of Pharmaceutics·A Caballero-QuinteroN Waksman
Nov 20, 1969·The New England Journal of Medicine·E M Sellers, J Koch-Weser
Sep 1, 1979·British Journal of Clinical Pharmacology·P A RoutledgeM D Rawlins
Jun 1, 1994·British Journal of Clinical Pharmacology·E ChanM Rowland
Dec 1, 1970·The Journal of Pharmacy and Pharmacology·J C Dearden, E Tomlinson
Feb 1, 1973·The Journal of Pharmacy and Pharmacology·J H Perrin, D A Nelson
Nov 1, 1975·The Journal of Pharmacy and Pharmacology·K F IlettL B Jellett
May 1, 1996·The Journal of Pharmacy and Pharmacology·R BajoriaS F Contractor
Jun 18, 1977·British Medical Journal·M L OrmeA M Breckenridge
Jan 1, 1969·The Journal of Clinical Investigation·R A O'Reilly
Jun 1, 1969·The Journal of Clinical Investigation·D S Lukas, A G De Martino
Mar 1, 1978·Biomedizinische Technik. Biomedical Engineering·A Kinawi, K Min
Jan 1, 1987·Reviews on Drug Metabolism and Drug Interactions·F A SutcliffeG G Gibson
Oct 1, 1980·Toxicology and Applied Pharmacology·D L Barber, H W Colvin
Sep 1, 1972·The American Journal of Medicine·I L Woolf, B M Babior
Jan 1, 1977·American Heart Journal·N Buchanan, L A Van der Walt
Apr 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·D G CovellM Berman
Feb 1, 1975·British Journal of Clinical Pharmacology·M J HayesA H Short
Feb 1, 1975·British Journal of Clinical Pharmacology·M J HayesA H Short
Jul 1, 1981·Biopharmaceutics & Drug Disposition·H L BehmJ G Wagner
Nov 26, 1973·Annals of the New York Academy of Sciences·R A O'Reilly
Jul 31, 1968·Annals of the New York Academy of Sciences·R A O'ReillyP M Aggeler
Sep 21, 2007·Photochemistry and Photobiology·Nihal KuşRui Fausto
Sep 15, 1984·Experientia·S Z CekanM Ritzén
Feb 14, 2012·Chemistry : a European Journal·Loïck MoriggiPeter Caravan
Feb 1, 1984·Acta Pharmacologica Et Toxicologica·R BrodersenF G Larsen
Feb 1, 1976·Acta Pharmacologica Et Toxicologica·R J JulkunenB Wahlström
Apr 8, 2000·Journal of Biomedical Science·C E HaN V Bhagavan
Sep 1, 1979·Acta Pharmacologica Et Toxicologica·S Husted, F Andreasen
Sep 1, 1976·Acta Pharmacologica Et Toxicologica·L FogedF Andreasen
Nov 15, 1973·Klinische Wochenschrift·R Gugler, H J Dengler
Feb 1, 1977·Biochemical Pharmacology·O G NilsenS Jacobsen
Jul 1, 1971·Biochemical Pharmacology·S Garten, W D Wosilait
Jan 1, 1973·Biochemical Pharmacology·O Bassir, E A Bababunmi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.